Abstract
AbstractIntroductionBreast cancer is the most common cancer in women in Saudi Arabia and the world (WHO 2020). Several studies have been published, worldwide, about the prognostic indicators of breast cancer, many of them showed a characteristic distribution according to certain geographical areasMethodsOver 20 years (1998-2018), the results of 498 patients diagnosed with breast cancer, have been collected from the archive of the pathology department at King Fahd University Hospital (KFHU).ResultsThis study included 498 patients diagnosed with breast cancer at King Fahd University Hospital over 20 years period (1998-2018), 58.4% (n=291) were Saudis. Data analysis showed a wide age distribution of breast cancers among eastern Saudi patients; however, most cases were seen in the 3rd and 4th decades. Luminal B was the most common subtype followed by triple-negative and luminal-A. Statistical analysis revealed a significant negative relationship between Saudi patients’ age at diagnosis and Her2 expression (P= .030), interestingly, this association was not significant in none-Saudi patients (P= .528).Discussion/ConclusionOur data revealed that breast cancer in Eastern Province had similar prognostics to international findings, however, Her2 profile and molecular subtype among Eastern Saudi women showed a minor deviation from worldwide published data.
Publisher
Cold Spring Harbor Laboratory
Reference22 articles.
1. Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population;Med Oncol,1999
2. Prospective breast cancer risk factors prediction in Saudi women;Saudi J Biol Sci,2020
3. Incidence Rates of Breast Cancer by Age and Tumor Characteristics Among Saudi Women: Recent Trends;Cureus,2020
4. Determinants of breast cancer in Saudi women from Makkah region: a case-control study (breast cancer risk factors among Saudi women);BMC Public Health,2019
5. Breast cancer molecular subtypes in oman: correlation with age, histology, and stage distribution - analysis of 542 cases;Gulf J Oncolog,2014